AstraZeneca Shares Dual Oncology Clinical and Regulatory Victories
AstraZeneca announced positive Phase 3 lung cancer trial results and earned EU approval for its Enhertu breast cancer combination.
AstraZeneca won two big wins: their lung cancer medicine worked well in testing, and Europe approved their breast cancer treatment. When a medicine company gets good test results and approvals, it usually means they're closer to helping patients and making money from those medicines.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.